Global /Canada /Healthcare /Biotechnology /MYND

MYND Life Sciences Inc.

MYND

• CSE: MYND • Delayed

0.0700CAD 0%

0.0502 USD

As of 7 June 2026, MYND Life Sciences Inc. has a market cap of $3.74M USD, ranking #45482 globally and #2169 in Canada. It ranks #4027 in the Healthcare sector, and #793 in the Biotechnology industry.

Global Rank

45482

Country Rank

2169

Sector Rank

4027

Industry Rank

793

Key Stats

Market Cap

$3.74MUSD

5.22M CAD

Enterprise Value

$5.89MUSD

8.22M CAD

Revenue (TTM)

$0.0000USD

1.00 CAD

EBITDA (TTM)

-$920.25KUSD

-1.28M CAD

Net Income (TTM)

-$388.95KUSD

-542.57K CAD

PS Ratio

5218346.0

PB Ratio

-0.9

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Biotechnology

CEO

John Campbell open_in_new

Website

myndsciences.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-	133%	-36%	133%	-30%	100%	-50%	-97%

Upcoming Earnings

Earnings Date

Tue, Jun 30

News

Markets

Exchange	Ticker	Price	Quotes
Canadian Securities Exchange (CSE) MIC: XCNQ PRIMARY	MYND MYND Life Sciences Inc Ordinary Shares ISIN: CA62857B1094 Shares Out.: Shares Outstanding: 47.817M¹ Shares Float: 47.817M² TV: TradingView: CSE: MYND SA: Stock Analysis: CSE: MYND YF: Yahoo Finance: MYND.CN GF: Google Finance: CNSX: MYND BA: Barron's: MYND MS: Morningstar: XCNQ: MYND	0.0700 CAD	TV: TradingView: CSE: MYND SA: Stock Analysis: CSE: MYND YF: Yahoo Finance: MYND.CN GF: Google Finance: CNSX: MYND BA: Barron's: MYND MS: Morningstar: XCNQ: MYND
OTC Markets (OTCMKTS / OTC) MIC: OTCM	MYNDF MYND Life Sciences Inc Ordinary Shares ISIN: CA62857B1094 TV: TradingView: OTC: MYNDF SA: Stock Analysis: OTC: MYNDF YF: Yahoo Finance: MYNDF GF: Google Finance: OTCMKTS: MYNDF BA: Barron's: MYNDF MS: Morningstar: PINX: MYNDF	0.0293 USD	TV: TradingView: OTC: MYNDF SA: Stock Analysis: OTC: MYNDF YF: Yahoo Finance: MYNDF GF: Google Finance: OTCMKTS: MYNDF BA: Barron's: MYNDF MS: Morningstar: PINX: MYNDF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About MYND Life Sciences Inc.

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.

Similar Companies

Industry: Biotechnology (Canada)

Name	Market Cap (USD) diff.	PE	Country
Aurinia Pharmaceuticals Inc. NASDAQ: AUPH	$1.99B 53K%	7.4	Canada
AbCellera Biologics Inc. NASDAQ: ABCL	$1.16B 31K%	-	Canada
Eupraxia Pharmaceuticals Inc. TSX: EPRX	$430.76M 600.89M CAD 11K%	-	Canada
NervGen Pharma Corp. TSXV: NGEN	$294.06M 410.19M CAD 8K%	-	Canada
Cybin Inc. NEO: CYBN	$253.15M 353.13M CAD 7K%	-	Canada
Cardiol Therapeutics Inc. TSX: CRDL	$149.17M 208.08M CAD 4K%	-	Canada

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 5M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 4M%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 1M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 1M%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 1M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 1M%	37.2	Switzerland

chevron_leftBack